@article {1480794,
	title = {Neuro-immune interactions in allergic diseases: novel targets for therapeutics},
	journal = {Int Immunol},
	volume = {29},
	number = {6},
	year = {2017},
	month = {2017 06 01},
	pages = {247-261},
	abstract = {Recent studies have highlighted an emerging role for neuro-immune interactions in mediating allergic diseases. Allergies are caused by an overactive immune response to a foreign antigen. The peripheral sensory and autonomic nervous system densely innervates mucosal barrier tissues including the skin, respiratory tract and gastrointestinal (GI) tract that are exposed to allergens. It is increasingly clear that neurons actively communicate with and regulate the function of mast cells, dendritic cells, eosinophils, Th2 cells and type 2 innate lymphoid cells in allergic inflammation. Several mechanisms of cross-talk between the two systems have been uncovered, with potential anatomical specificity. Immune cells release inflammatory mediators including histamine, cytokines or neurotrophins that directly activate sensory neurons to mediate itch in the skin, cough/sneezing and bronchoconstriction in the respiratory tract and motility in the GI tract. Upon activation, these peripheral neurons release neurotransmitters and neuropeptides that directly act on immune cells to modulate their function. Somatosensory and visceral afferent neurons release neuropeptides including calcitonin gene-related peptide, substance P and vasoactive intestinal peptide, which can act on type 2 immune cells to drive allergic inflammation. Autonomic neurons release neurotransmitters including acetylcholine and noradrenaline that signal to both innate and adaptive immune cells. Neuro-immune signaling may play a central role in the physiopathology of allergic diseases including atopic dermatitis, asthma and food allergies. Therefore, getting a better understanding of these cellular and molecular neuro-immune interactions could lead to novel therapeutic approaches to treat allergic diseases.},
	keywords = {Animals, Humans, Hypersensitivity, Inflammation, Molecular Targeted Therapy, Mucous Membrane, Nervous System, Neuroimmunomodulation, Neuropeptides, Receptor Cross-Talk},
	issn = {1460-2377},
	doi = {10.1093/intimm/dxx040},
	author = {Voisin, Tiphaine and Bouvier, Am{\'e}lie and Chiu, Isaac M}
}
